Circulation, 131, 54-61 CIRCULATION r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname Circulation, 131(1), 54-61. United States (2015). PARADIGM-HF Investigators and Coordinators 2015, ' Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure ', Circulation, vol. 131, no. 1, pp. 54-61 . https://doi.org/10.1161/CIRCULATIONAHA.114.013748 Circulation, 131, 1, pp. 54-61
McMurray, J, Packer, M, Desai, A, Gong, J, Greenlaw, N, Lefkowitz, M, Rizkala, A, Shi, V, Rouleau, J, Solomon, S, Swedberg, K, Zile, M R, Andersen, K, Arango, J L, Arnold, M, Bĕlohlávek, J, Böhm, M, Boytsov, S, Burgess, L, Cabrera, W, Chen, C-H, Erglis, A, Fu, M, Gomez, E, Gonzalez, A, Hagege, A-A, Katova, T, Kiatchoosakun, S, Kim, K-S, Bayram, E, Martinez, F, Merkely, B, Mendoza, I, Mosterd, A, Negrusz-Kawecka, M, Peuhkurinen, K, Ramires, F, Refsgaard, J, Senni, M, Sibulo, A S, Silva-Cardoso, J, Squire, I, Starling, R C, Vinereanu, D, Teerlink, J R, Wong, R & PARADIGM-HF Committees and Investigators 2015, ' A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure ', European Heart Journal, vol. 36, no. 7, pp. 434-9 . https://doi.org/10.1093/eurheartj/ehu455 European Heart Journal